| Table 1. Basic characteristics of women with ovarian hyperstimulation syndrome (OHSS). | ||||
| All (n=71) |
Moderate OHSS (n=38) |
Severe OHSS (n=31) |
p | |
|---|---|---|---|---|
| Baseline characteristic Age, yrs BMI, kg/m2 |
32.7±4.1 22.8±5.0 |
33.0±3.9 21.2±3.6 |
32.3±4.4 24.6±5.8 |
0.44 0.07 |
| Concomitant diseases, n -Not related to infertility, n DM Hypothyroidism AH Varicose veins -Infertility cause, n PCOS Tubal Male Endometriosis Unexplained |
3 7 2 1 20 15 15 16 3 |
2 4 1 1 11 7 10 8 2 |
1 3 1 0 9 8 5 8 1 |
- - - - - - - - - |
| Time from OPU, days | 4.6±0.9 | 4.5±0.9 | 4.8±0.8 | 0.17 |
| ET, n | 44 | 24 | 20 | 0.14 |
| Protocol type Agonist Antagonist |
40 29 |
18 (43.4) 20 (52.6) |
22 (71.0) 9 (29.0) |
0.047 |
| Ovarian size, mm Right Left |
100 [86-130] 80 [73.4-99.4] |
88.3 [83.5-97.8] 76.0 [69.5-80.0] |
131 [122.0-144.5] 99.8 [81.0-120.0] |
<0.001 <0.001 |
| Ultrasound ascites, n (%) | 24 (63.2) | 4 (12.9) | - | |
| Clinical ascites, n (%) | - | 0 (0) | 23 (74.2) | - |
| Pleural effusion, n (%) | - | 0 (0) | 14 (45.2) | - |
| Pericardial effusion, n (%) | - | 0 (0) | 3 (9.7) | - |
| Treatment Cabergoline, n Albumin, n Furosemide, n |
59 21 30 |
33 7 10 |
26 14 20 |
0.31 0.03 0.03 |
Values are given as mean ± SD, median (interquartile range), or percentage.
Abbreviations: BMI, body mass index; OHSS, ovarian hyperstimulation syndrome; OPU, oocyte pick-up; ET, embryo transfer; DM, diabetes mellitus; AH, arterial hypertension; PCOS, polycystic ovary syndrome.